Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation-Reference-Cited by-同舟云学术

Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation

Published:2022-06-09 Issue:2 Volume:112 Page:353-363
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Terrier Jean¹²³^ORCID,Gaspar Frédéric⁴⁵⁶,Guidi Monia⁴⁶⁷,Fontana Pierre²⁸^ORCID,Daali Youssef²³,Csajka Chantal⁴⁵⁶,Reny Jean‐Luc¹²^ORCID

Affiliation:

1. Division of General Internal Medicine Geneva University Hospitals Geneva Switzerland

2. Geneva Platelet Group, Faculty of Medicine University of Geneva Geneva Switzerland

3. Clinical Pharmacology and Toxicology Service, Anesthesiology Pharmacology and Intensive Care Department Geneva University Hospitals Geneva Switzerland

4. Center for Research and Innovation in Clinical Pharmaceutical Sciences Lausanne University Hospital and University of Lausanne Lausanne Switzerland

5. School of Pharmaceutical Sciences University of Geneva Geneva Switzerland

6. Institute of Pharmaceutical Sciences of Western Switzerland University of Geneva, University of Lausanne Geneva Switzerland

7. Service of Clinical Pharmacology Lausanne University Hospital and University of Lausanne Lausanne Switzerland

8. Division of Angiology and Haemostasis Geneva University Hospitals Geneva Switzerland

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2649

Reference51 articles.

1. Update on Guidelines for the Management of Cancer-Associated Thrombosis

2. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

3. Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

4. Laboratory Monitoring of Non–Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation

5. Overview of model-building strategies in population PK/PD analyses: 2002–2004 literature survey

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Anticoagulants Beyond Warfarin;Annual Review of Pharmacology and Toxicology;2024-01-23

2. Population pharmacokinetics of apixaban in a real‐life hospitalized population from the OptimAT study;CPT: Pharmacometrics & Systems Pharmacology;2023-09-18

3. Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban;Pharmaceutics;2023-02-09

4. Effect of Genotype on the Pharmacokinetics and Bleeding Events of Direct Oral Anticoagulants: A Systematic Review and Meta‐analysis;The Journal of Clinical Pharmacology;2022-11-16

5. Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics;Clinical Pharmacology & Therapeutics;2022-08-04